University of Cincinnati Cancer Center

Meet Keilan Johnson, a fourth-year MD-MPH candidate at the University of Cincinnati College of Medicine and a dedicated member of our Trainee Associate Membership Program. From planning community events in Cincinnati’s neighborhoods to pursuing research that improves patient-physician communication, Keilan is making a real impact in cancer care and beyond. Earlier this year, Keilan received both a TAM and Travel Award for her project, “Community Engagement Work as a Model for Increasing Cancer Screening among Underserved Communities in Cincinnati.” Through the TAM program, Keilan has connected with mentors, received valuable professional development opportunities, and found support for her research and community initiatives. She emphasizes the importance of building connections and fully utilizing available resources, shaping her approach to both her studies and her future career in medicine. Learn more about Keilan's work and involvement with the TAM program: https://lnkd.in/gR9D5NYq

We’re proud to highlight the transformative impact of Ride Cincinnati on our cancer research. Blood cancers are a strategic priority for our Cancer Center, and thanks to a $50,000 Pilot Project Award funded by Ride Cincinnati, Erin Hertlein, PhD, is leading a critical project to identify mechanisms of immune suppression in Acute Myeloid Leukemia. Since 2018, Ride Cincinnati has funded over 80 research projects at the University of Cincinnati Cancer Center, driving innovation and improving health outcomes in our region. Join this fun, impactful event next weekend and help us continue this life-saving work. It's not too late to sign up. Riders can choose 10, 15, 24, 36 or 64 miles or choose the virtual option. https://lnkd.in/g52Uz4S2

We’re proud to highlight the transformative impact of Ride Cincinnati on our cancer research. Blood cancers are a strategic priority for our Cancer Center, and thanks to a $50,000 Pilot Project Award funded by Ride Cincinnati, Erin Hertlein, PhD, is leading a critical project to identify mechanisms of immune suppression in Acute Myeloid Leukemia. Since 2018, Ride Cincinnati has funded over 80 research projects at the University of Cincinnati Cancer Center, driving innovation and improving health outcomes in our region. Join this fun, impactful event next weekend and help us continue this life-saving work. It's not too late to sign up. Riders can choose 10, 15, 24, 36 or 64 miles or choose the virtual option. https://lnkd.in/d9UPXdJT

This September, we recognize Childhood Cancer Awareness Month, a time to reflect on the challenges and progress in pediatric cancer care. While pediatric cancers are relatively rare, they are the leading cause of death from disease in children aged 1 to 14. Thanks to ongoing research and innovative treatments, the five-year survival rate has improved significantly from 58-68% in the 1970s to 83-88% today. At the University of Cincinnati Cancer Center, we are dedicated to advancing cancer research and care across the lifespan. Our partners at Cincinnati Children's, the nation’s #1 ranked children’s hospital, are key to this mission. Their Cancer and Blood Diseases Institute (CBDI) leads globally in treating and researching high-risk, relapsed, and refractory cancers, blood diseases, and immune deficiencies in children and young adults. Alongside the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center, these teams deliver comprehensive, innovative care from bench to bedside, continually improving outcomes for patients and their families. September brings awareness to multiple cancers—follow along this month to learn more about the University of Cincinnati Cancer Center’s impact across these areas.

We're proud of the impact that Ride Cincinnati's funds have on cancer research in our community. Thanks to this support, researchers like Jordan Kharofa, MD, are advancing treatments for cancers most prevalent in our catchment area, such as anal cancer. Dr. Kharofa’s REDEL Trial is pioneering a new approach to reduce treatment toxicity, directly benefiting patients. This work not only drives innovation but also brings us closer to our mission of improving health outcomes in our community. Read the full story: https://lnkd.in/g3cgDetw #CancerResearch

Congratulations to Alique Topalian, PhD, MPH, on receiving the Inspirational Award from the Armenian Bone Marrow Donor Registry! Dr. Topalian's journey and dedication inspire us all. The ABMDR, which was founded during her first battle with acute myeloid leukemia, has since registered over 30,000 donors and performed 44 life-saving transplants, bringing vital resources and innovation to Armenia. We are honored to celebrate her remarkable journey and contributions to advancing life-saving resources and innovation in the Caucasus region.

Cincinnati Magazine's 11th annual Slice Night returns to Yeatman's Cove on Wednesday, September 11, from 5:30-8:30 p.m., offering all-you-can-eat pizza to benefit the University of Cincinnati Cancer Center. 🍕 Don't miss the fun: https://lnkd.in/g9yTWjbk

Congrats to Cancer Center members Chenran Wang, PhD, Amanda Wasylishen, PhD, Yanbo Fan, MD, PhD, and Ady Kendler, MD, PhD, on their new publication! Their research introduces a novel 3D co-culture platform using human cerebral organoids to model breast cancer brain metastasis. This innovative approach has revealed that certain breast cancer cells, like MDA-MB-231 and SUM159PT, can invade and form colonies in the brain, advancing our understanding of the tumor microenvironment and potentially leading to more effective therapies for patients. Learn more: https://lnkd.in/gS9pnEhp

As this year's Ride Cincinnati ride weekend approaches, we reflect on the impactful cancer research made possible through their unwavering support. Since 2018, RIDE Cincinnati has been instrumental in funding over 80 research projects at the University of Cincinnati Cancer Center through our Pilot Project Award Program, which enables faculty investigators to explore innovative and collaborative approaches in cancer research. Help Cincinnati become the smartest city for cancer research and care by getting involved. Join one of the Cancer Center's 18 Ride Cincinnati Peloton Teams based on disease sites, research programs, and other Cancer Center supporting teams. Fundraising dollars support clinical trials, provide seed funding for novel ideas, and enable large studies that help us better understand the health of Cincinnatians. To learn more and register, visit: https://lnkd.in/gAUhHUBy

Congratulations to Cancer Center members Andrew Frankard, MD, Sesh Rai, PhD, and Vinita Takiar, MD, PhD, on their new publication in Oral Oncology. Their research demonstrates that oral cavity cancer patients with a treatment package time (TPT) of less than 105 days experience significantly better survival outcomes, highlighting the critical importance of timely, coordinated care. Read more about the study: https://lnkd.in/dQ4YiFKa